ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma
Open Access
- 1 May 2005
- journal article
- guideline
- Published by Elsevier BV in Annals Of Oncology
- Vol. 16 (suppl_1), i66-i68
- https://doi.org/10.1093/annonc/mdi809
Abstract
1Invited author and member of the task force, Oncology, Kantonsspital, CH-4101 Bruderholz/BL, Switzerland; 2Assigned task force member, Institute of Oncology and Radiology of Serbia, Department of Medical Oncology, Pasterova 14, 11000 Belgrade, Serbia; 3Assigned task force member, P. Stradins University Hospital, Radiation & Chemotherapy Center, Pilsonu Str. 13, 1002 Riga, LatviaThis publication has 11 references indexed in Scilit:
- Immunologic and Clinical Outcomes of Vaccination With a Multiepitope Melanoma Peptide Vaccine Plus Low-Dose Interleukin-2 Administered Either Concurrently or on a Delayed ScheduleJournal of Clinical Oncology, 2004
- Mature results of a phase III randomized trial of bacillus Calmette–Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I–III melanoma (E1673)Cancer, 2004
- Excision Margins in High-Risk Malignant MelanomaNew England Journal of Medicine, 2004
- Adjuvant Interferon in High-Risk Melanoma: The AIM HIGH Study—United Kingdom Coordinating Committee on Cancer Research Randomized Study of Adjuvant Low-Dose Extended-Duration Interferon Alfa-2a in High-Risk Resected Malignant MelanomaJournal of Clinical Oncology, 2004
- Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferonPsycho‐Oncology, 2003
- Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant MelanomaJournal of Clinical Oncology, 2000
- Isolated limb perfusion with tumour necrosis factor-α and melphalan with or without interferon-γ; for the treatment of in-transit melanoma metastasesMelanoma Research, 1999
- Prospective Study of Fluorodeoxyglucose–Positron Emission Tomography Imaging of Lymph Node Basins in Melanoma Patients Undergoing Sentinel Node BiopsyJournal of Clinical Oncology, 1999
- Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trialThe Lancet, 1998
- Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.Journal of Clinical Oncology, 1996